Micron Biomedical, an Atlanta-based biotech company, secured an additional $3 million investment from J2 Ventures, bringing their Series A round total to $17 million The company was founded in 2014 by Mark Prausnitz, Devin McAllister, and Sebastien Henry to develop dissolvable microneedle patch technology for vaccine delivery Micron Biomedical's vaccine patch uses biocompatible polymer microneedles that dissolve after insertion, enabling painless vaccine delivery through the skin The technology eliminates the need for refrigeration and needle disposal, reducing vaccine distribution costs and complexity The company is developing vaccine patches for COVID-19, cancer, and other chronic diseases, with the technology currently in the development phase showing promising preclinical results The Series A round was initiated in November 2022 and led by Global Health Investment Corporation (GHIC) and LTS Lohmann with participation from GRA Venture Fund Dr. Matt Goldman from J2 Ve...
- Get link
- X
- Other Apps